|
|
Current Studies
| Condition |
Additional Trial Information |
|
Anticoagulant Reversal
|
Efficacy and Safety Study of BERIPLEX® P/N Compared With Plasma in Patients on Anticoagulant Therapy Who Require Emergency Surgery or Invasive Intervention
> Learn More
|
|
Congenital Fibrinogen Deficiency
|
Fibrinogen Concentrate (Human) − Efficacy and Safety Study
> Learn More
|
|
Emphysema Caused by API Deficiency
|
Study of Zemaira i.v. Administration in Subjects Who Completed a 2-Year Controlled Study With This Treatment and Have Emphysema Due to alpha1 -Proteinase Inhibitor Deficiency.
> Learn More
|
|
Emphysema Caused by API Deficiency
|
Zemaira in Subjects With Emphysema Due to Alpha1-Proteinase Inhibitor (API) Deficiency
> Learn More
|
|
Healthy
|
A Single Ascending Dose Study Examining the Safety and Pharmacokinetic Profile of Reconstituted High Density Lipoprotein (CSL112) Administered to Patients
> Learn More
|
|